Filter Results
:
(6,308)
Show Results For
-
All HBS Web
(6,308)
- People (20)
- News (2,173)
- Research (3,018)
- Events (8)
- Multimedia (212)
- Faculty Publications (2,044)
Show Results For
-
All HBS Web
(6,308)
- People (20)
- News (2,173)
- Research (3,018)
- Events (8)
- Multimedia (212)
- Faculty Publications (2,044)
- 20 Dec 2021
- News
Care Is Needed to Ensure the Hybrid Office Works for All
- Web
Women, Work, and the “M” Word - Blog: Health Supplement
Blog Blog Health Supplement Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Blavatnik Fellow Author Blavatnik Fellowship Team Author Executive Education Author HBS Partners Author HBS Staff Author View Details
- November–December 2015
- Article
Active Postmarketing Drug Surveillance for Multiple Adverse Events
By: Joel Goh, Margrét V. Bjarnadóttir, Mohsen Bayati and Stefanos A. Zenios
Postmarketing drug surveillance is the process of monitoring the adverse events of pharmaceutical or medical devices after they are approved by the appropriate regulatory authorities. Historically, such surveillance was based on voluntary reports by medical...
View Details
Keywords:
Drug Surveillance;
Health Care;
Stochastic Models;
Queueing;
Diffusion Approximation;
Brownian Motion;
Health Care and Treatment;
Analytics and Data Science;
Analysis
Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios. "Active Postmarketing Drug Surveillance for Multiple Adverse Events." Operations Research 63, no. 6 (November–December 2015): 1528–1546. (Finalist, 2012 INFORMS Health Applications Society Pierskalla Award.)
- 2004
- Book
Consumer-Driven Health Care: Implications for Providers, Payers, and Policymakers
Herzlinger, Regina E. Consumer-Driven Health Care: Implications for Providers, Payers, and Policymakers. San Francisco: Jossey-Bass, 2004.
- January 2017 (Revised March 2021)
- Case
Fitbit
By: Regina E. Herzlinger, Christine Snively and Sarah Mehta
In 2019, Fitbit lost its leadership in the wearable sensor market to Apple and to cheaper alternatives.
Why did it lose its market position?
How will the proposed acquisition affect it and Google? View Details
Why did it lose its market position?
How will the proposed acquisition affect it and Google? View Details
- September 2023
- Teaching Note
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
Teaching Note for HBS Case No. 304-009. The case is part of the first module of the Innovating in Health Care course. Its purpose is to demonstrate how to evaluate the “do good” and do well” potential of a health care innovation.
View Details
- October 2013 (Revised January 2015)
- Case
The Slingshot: Improving Water Access
By: John A. Quelch, Margaret L. Rodriguez and Carin-Isabel Knoop
In 2012, over 750 million people around the globe lacked access to safe drinking water. Dean Kamen, inventor of the Segway, sought to bring fresh water to poor and rural areas with the Slingshot, a water purification device. Kamen's challenge was to identify ways to...
View Details
Keywords:
Water;
Public Health;
Health Care;
Slingshot;
Dean Kamen;
DEKA;
Coca-Cola;
Developing Markets;
Freestyle;
Safety;
Natural Environment;
Pollutants;
Health;
Distribution Channels;
Developing Countries and Economies;
Innovation and Invention;
Africa;
Latin America;
South America;
Asia
Quelch, John A., Margaret L. Rodriguez, and Carin-Isabel Knoop. "The Slingshot: Improving Water Access." Harvard Business School Case 514-007, October 2013. (Revised January 2015.)
- 05 Jul 2006
- Working Paper Summaries
Implementing New Practices: An Empirical Study of Organizational Learning in Hospital Intensive Care Units
- 09 Nov 2023
- HBS Case
What Will It Take to Confront the Invisible Mental Health Crisis in Business?
health research fund after his son experienced a psychotic break. In the following interview, Cohen, the L.E. Simmons Professor of Business Administration at HBS, discusses why it’s important for organizations to address mental View Details
- 2013
- Working Paper
Work Design Drivers of Organizational Learning about Operational Failures: A Laboratory Experiment on Medication Administration
By: Anita L. Tucker
Operational failures persist in hospitals, in part because employees work around them rather than attempt to prevent recurrence. Drawing on a process improvement tool—the Andon cord—we examine three work design components that may foster improvement-oriented behaviors:...
View Details
Keywords:
Health Care;
Process Improvement;
Organizational Learning;
Behavioral Operations;
Prosocial Behavior;
Experiments;
Organizational Change and Adaptation;
Behavior;
Performance Improvement;
Health Care and Treatment;
Business Processes;
Health Industry
Tucker, Anita L. "Work Design Drivers of Organizational Learning about Operational Failures: A Laboratory Experiment on Medication Administration." Harvard Business School Working Paper, No. 13-044, November 2012. (Revised September 2013.)
- 16 May 2017
- Blog Post
Making the Move into Digital Health and Software Engineering
US, UK, Canada and India. It was crazy. Harvard also provided many academic opportunities during the Second Year to build my technical and digital health skill set. Last fall, Julia Austin, a Senior Lecturer...
View Details
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby...
View Details
Keywords:
Health Care;
Biosimilars;
Biologics;
Pharmaceutical Competition;
Healthcare Spending;
Innovation;
Health Care and Treatment;
Spending;
Market Entry and Exit;
Competition;
Innovation and Invention;
Pharmaceutical Industry;
United States;
Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- 12 Oct 2015
- News
Google Ventures: Big-time Consumer Health Is Still a Dream
- August 2008
- Teaching Note
Go Red for Women: Raising Heart Health Awareness (TN)
By: V. Kasturi Rangan and Marie Madelene Bell
Teaching Note for [507026].
View Details
- September 2014 (Revised February 2015)
- Case
Pfizer and AstraZeneca: Marketing an Acquisition (A)
By: John A. Quelch and James Weber
In 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for pharmaceutical consumers? Pfizer, like pharmaceutical companies in general, faced difficulties in growing sales due to...
View Details
Keywords:
Health Care Policy;
Mergers And Acquisitions;
Marketing;
Government Relations;
Crisis Management;
Decision Making;
Growth and Development;
Management;
Markets;
Strategy;
Pharmaceutical Industry;
United Kingdom;
United States
Quelch, John A., and James Weber. "Pfizer and AstraZeneca: Marketing an Acquisition (A)." Harvard Business School Case 515-007, September 2014. (Revised February 2015.)
- 23 Apr 2014
- News
Are Electronic Cigarettes a Public Good or Health Hazard?
- 01 Sep 2007
- News
‘Redefining Health Care’: Medical Homes or Archipelagos to Navigate?
- 07 Feb 2007
- News
A Failing Transparency of Design Principles in Health Care?
- March 2010
- Teaching Note
Narayana Hrudayalaya Heart Hospital: Cardiac Care for the Poor (TN)
By: Tarun Khanna and V. Kasturi Rangan
Teaching Note for [505078].
View Details